147 related articles for article (PubMed ID: 7512660)
1. Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia.
Monda JM; Barry MJ; Oesterling JE
J Urol; 1994 May; 151(5):1291-5. PubMed ID: 7512660
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer].
Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 1998 Sep; 44(9):639-43. PubMed ID: 9805668
[TBL] [Abstract][Full Text] [Related]
3. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
Jones JS; Follis HW; Johnson JR
Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
[TBL] [Abstract][Full Text] [Related]
4. Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers.
Tombal B; De Visccher L; Cosyns JP; Lorge F; Opsomer R; Wese FX; Van Cangh PJ
BJU Int; 1999 Dec; 84(9):1015-20. PubMed ID: 10571626
[TBL] [Abstract][Full Text] [Related]
5. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
6. Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer.
Sershon PD; Barry MJ; Oesterling JE
Eur Urol; 1994; 25(4):281-7. PubMed ID: 7519989
[TBL] [Abstract][Full Text] [Related]
7. [Prostate cancer: comparative study of stage T1a and stage T1b].
Lefi M; Hellara W; Touffahi M; Fredj N; Adnene M; Saidi R; Saad H
Prog Urol; 2007 Nov; 17(7):1343-6. PubMed ID: 18271419
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer detection in candidates for open prostatectomy.
Fowler JE; Bigler SA; Kolski JM
J Urol; 1998 Dec; 160(6 Pt 1):2107-10. PubMed ID: 9817333
[TBL] [Abstract][Full Text] [Related]
9. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
Epstein JI; Walsh PC; Brendler CB
J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719
[TBL] [Abstract][Full Text] [Related]
10. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b.
Masue N; Deguchi T; Nakano M; Ehara H; Uno H; Takahashi Y
Int J Urol; 2005 Dec; 12(12):1045-9. PubMed ID: 16409608
[TBL] [Abstract][Full Text] [Related]
11. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of patients with stage T1b incidental prostate cancer.
Argyropoulos A; Doumas K; Farmakis A; Aristas O; Kontogeorgos G; Lykourinas M
Scand J Urol Nephrol; 2005; 39(4):289-93. PubMed ID: 16118104
[TBL] [Abstract][Full Text] [Related]
13. Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening.
Mai KT; Isotalo PA; Green J; Perkins DG; Morash C; Collins JP
Arch Pathol Lab Med; 2000 Oct; 124(10):1454-6. PubMed ID: 11035574
[TBL] [Abstract][Full Text] [Related]
14. Measurement of prostate specific antigen and gamma-seminoprotein ratio: a new means of distinguishing benign prostatic hyperplasia and prostate cancer.
Demura T; Watarai Y; Togashi M; Hirano T; Ohashi N; Koyanagi T
J Urol; 1993 Nov; 150(5 Pt 2):1740-5. PubMed ID: 7692111
[TBL] [Abstract][Full Text] [Related]
15. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
Bales GT; Flynn TJ; Kynaston HG; Golash A; Hart A; Kim HL; Gerber GS
Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
[TBL] [Abstract][Full Text] [Related]
16. Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia.
Marks LS; Dorey FJ; Rhodes T; Shery ED; Rittenhouse H; Partin AW; deKernion JB
J Urol; 1996 Sep; 156(3):1035-9. PubMed ID: 8709302
[TBL] [Abstract][Full Text] [Related]
17. Trends in diagnosis of stage T1a-b prostate cancer.
Fowler JE; Pandey P; Bigler SA; Yee DT; Kolski JM
J Urol; 1997 Nov; 158(5):1849-52. PubMed ID: 9334615
[TBL] [Abstract][Full Text] [Related]
18. [Incidental prostatic cancer].
Herranz Amo F; Díez Cordero JM; Verdú Tartajo F; Leal Hernández F; Bielsa Carrillo A; García Burgos J; Subirá Ríos D
Actas Urol Esp; 1999; 23(10):848-52. PubMed ID: 10670126
[TBL] [Abstract][Full Text] [Related]
19. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
Ornstein DK; Rao GS; Smith DS; Andriole GL
J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of T1a-T1b prostate cancer].
Liu Z; Luo C; Hu S; Fan Y; Liu ZH; Yang XY; Shen Q; Liu LB; Han WK; Zhou LQ; Yu W; He Q; Zhang Q; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):812-816. PubMed ID: 27752161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]